CMS Medicare Formulary Reviews Include 14 Checkpoints
Executive Summary
The Centers for Medicare & Medicaid Services has a 14-point checklist it is using in the review of Medicare Part D drug formularies
You may also be interested in...
Part D Sponsors Will Develop Plans To Target Dual-Eligibles, Panel Says
Medicare Part D plan sponsors will develop specific prescription drug plans to target dual-eligible beneficiaries, panelists said during a Kaiser Family Foundation workshop on Medicare formularies March 14 in Washington, D.C
Medicare Formularies Should Contain “Majority” Of Drugs In Six Classes
Medicare drug plan formularies will be expected to cover the "majority" of products in six specific drug classes, the Centers for Medicare & Medicaid Services final formulary review guidelines state
USP Final Formulary Guide Adds PPI Class, But Has Few Other Changes
Proton pump inhibitors may be the only commercially significant group of drugs to gain "pharmacologic class" status in the revisions to U.S. Pharmacopeia's model guidelines for Medicare drug plans